Semaglutide Patent Expirations: Ozempic & Wegovy Timeline
Novo Nordisk aims to launch more than five blockbuster drugs by 2030, according to its Chief Executive Officer, as the Danish pharmaceutical giant prepares for upcoming patent expirations for semaglutide, … Read More